Phase 3 Tuberculosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The baby must be male or female and enrolled within the first seven days after birth.
- The mother must give written permission for her baby to take part, including allowing access to her own and her baby's medical records.
- The family must be willing and able to attend follow-up appointments and take part in all study activities.
- The baby must have been considered healthy during pregnancy and at birth, based on medical history and a physical check-up.
- The baby must have weighed at least 2,450 grams (about 5.4 pounds) at birth.
- The baby must have received an Apgar score (a quick health check done at birth) of 7 or higher at 5 minutes after birth.
- A recent HIV test result for the mother must be on record — if she does not have HIV, the test must have been done within 30 days before or 7 days after delivery; if she does have HIV, she must be on HIV treatment with a very low level of virus in her blood.
- The baby must have been born at or after 37 weeks of pregnancy (full term).
- The mother must not have taken part in any clinical trial in the three months before the baby's birth.
- The mother must never have taken part in a tuberculosis (TB) vaccine trial before.
- The baby must not be enrolled in any other clinical trials at the same time.
Who may not be able to join:
- The baby has already received a BCG vaccine (a vaccine commonly given at birth to protect against TB) before joining the trial.
- There were serious complications during or after pregnancy that could affect the baby's health.
- There is a skin problem, bruise, or birthmark at the spot on the body where the injection would be given.
- The mother's HIV test result is not available.
- The baby was exposed to HIV and their own HIV test result came back positive or is not yet available.
- The mother had tuberculosis (TB) during pregnancy.
- Anyone in the baby's home has TB and has not yet finished their TB treatment.
- The baby shows signs of a serious blood infection (neonatal sepsis).
- The baby was born with a severe physical abnormality.
- The baby has any signs of a serious illness or condition that, in the doctor's judgement, could affect how the trial results are measured (mild newborn jaundice on its own does not count as a reason to exclude the baby).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mark Hatherill, University of Cape Town, Faculty of Health Sciences
Phone: +34 986 33 04 00
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To demonstrate efficacy in terms of incidence of MTBVAC against TB disease in healthy HU and HEU newborns compared to BCG
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.